Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire

Blood. 2003 Apr 15;101(8):3082-4. doi: 10.1182/blood-2002-08-2432. Epub 2002 Dec 12.

Abstract

Chronic lymphocytic leukemia (CLL) comprises 2 subsets, distinguished by expression of unmutated or mutated V(H) genes, with the former having a worse prognosis. Biased usage of the V1-69 gene is found in unmutated cases and is combined with selected D gene segments and J(H)6. It is controversial whether this is a CLL-associated feature or mirrors the normal B-cell pattern. Since CLL is a disease of the elderly, where changes in the B-cell repertoire may occur, we have analyzed V1-69 usage in the elderly (older than 75 years) population. Using monoclonal antibody (MoAb) G6, specific for 51p1-related V1-69 alleles, we found no increased expression with age. In 51p1-encoded immunoglobulin M (IgM), complementarity-determining region 3 (CDR3) length and frequency of D and J(H) genes were similar to those in the healthy young and distinct from those in CLL. These findings support the concept that CLL arises from B cells driven by antigen/superantigen and is not a stochastic event in the elderly B-cell population.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aging / genetics
  • Aging / immunology*
  • Antibodies, Monoclonal / immunology
  • B-Lymphocytes / chemistry
  • B-Lymphocytes / pathology
  • CD5 Antigens / immunology
  • Cohort Studies
  • Female
  • Gene Library
  • Gene Rearrangement, B-Lymphocyte*
  • Genes, Immunoglobulin*
  • Humans
  • Immunoglobulin M / metabolism
  • Immunoglobulin Variable Region / genetics*
  • Immunophenotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Neoplasm Proteins / genetics*
  • Neoplastic Stem Cells / chemistry
  • Neoplastic Stem Cells / pathology
  • Superantigens / immunology

Substances

  • Antibodies, Monoclonal
  • CD5 Antigens
  • Immunoglobulin M
  • Immunoglobulin Variable Region
  • Neoplasm Proteins
  • Superantigens